Lilly and Novo near White House deal on obesity drug pricesnews2025-11-04T15:19:45+00:00November 4th, 2025|Endpoints News|
Updated: Novo ups Metsera bid to as much as $10B in attempt to top Pfizer’s new offernews2025-11-04T14:44:43+00:00November 4th, 2025|Endpoints News|
GoodRx wants in on TrumpRx as it grows its work with manufacturersnews2025-11-04T14:00:47+00:00November 4th, 2025|Endpoints News|
Jennifer Doudna startup Azalea Therapeutics launches with $82Mnews2025-11-04T13:00:49+00:00November 4th, 2025|Endpoints News|
As pharma pour billions in US manufacturing, CDMOs see future opportunitiesnews2025-11-04T13:00:34+00:00November 4th, 2025|Endpoints News|
Swiss biotech CDR-Life returns to Boehringer Ingelheim to partner on autoimmune T cell engagernews2025-11-04T13:00:32+00:00November 4th, 2025|Endpoints News|
Blackstone to pay Merck $700M to fund development of antibody-drug conjugatenews2025-11-04T12:29:04+00:00November 4th, 2025|Endpoints News|
Pfizer trims pipeline, reports 7% revenue decline for Q3news2025-11-04T12:07:42+00:00November 4th, 2025|Endpoints News|
South Korean biotech sets up California startup to advance ADCsnews2025-11-04T12:00:25+00:00November 4th, 2025|Endpoints News|
Post-Hoc Live: M&A, FDA, MFN and more — with our cousins at the FTnews2025-11-04T12:00:13+00:00November 4th, 2025|Endpoints News|
